-
AveXis (AVXS) Prices 3.92M Share Common Offering at $102/Sh
-
AveXis Announces Pricing of Public Offering of Common Stock
-
AveXis Announces Pricing of Public Offering of Common Stock
-
AveXis (AVXS) Plans $400M Common Stock Offering
-
AveXis Announces Proposed Public Offering of Common Stock
-
AveXis Announces Proposed Public Offering of Common Stock
-
AveXis (AVXS): Data Could Support 2H18 Approval of AVXS-101 - BMO
-
AveXis (AVXS): AVXS-101 Abstracts Could Highlight The Next Driver - BMO
-
AveXis Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
AveXis (AVXS) Prices 3.75M Shares Offering; Net Proceeds Expected to be Roughly $234.5M
-
AveXis Announces Pricing of Public Offering of Common Stock
-
AveXis (AVXS) Plans $200M Common Stock Offering
-
AveXis Announces Proposed Public Offering of Common Stock
-
AveXis (AVXS): FDA In Alignment Offsets Trial Delay - BMO
-
AveXis (AVXS): Raising PT on Strong P1 Data - BMO
-
Spinraza Prices Leaves Door 'Wide Open' for AveXis' (AVXS) AVXS-101 - BMO Capital
-
Today's Biotech Upside Could Be Just the Start - BMO Capital (IBB) (XBI)
-
AveXis (AVXS) PT Raised to $80 at BMO Capital Following AVXS-101 Update
-
AveXis (AVXS): World Muscle Society Data Supports Remarkable Efficacy In Infants - BMO
-
AveXis (AVXS) Prices 4.25M Common Stock Offering for Proceeds of ~$128M
-
AveXis Announces Pricing of Public Offering of Common Stock
-
AveXis (AVXS) to Offer 4M Shares of Common Stock
-
AveXis Announces Proposed Public Offering of 4,000,000 Shares of Common Stock
-
Vertex (VRTX), BioMarin (BMRN), Intercept (ICPT), Others Highlighted as Targets at BMO Following PFE/MDVN
-
Notable Analyst Rating Changes 3/28: (PRXL) (FINL) (THG) Upgraded; (XONE) (PH) (ATW) Downgraded
-
Notable Analyst Rating Changes 3/7: (GGP) (MT) (UDR) Upgraded; (MU) (SSYS) (IHG) Downgraded
-
BMO Capital Starts AveXis (AVXS) at Outperform
-
AveXis (AVXS) IPO Opens Down 10%
-
AveXis Announces Pricing of Initial Public Offering
-
AveXis (AVXS) Files $115M IPO

